4//SEC Filing
Newman Mark 4
Accession 0001209191-23-016099
CIK 0001627223other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:09 PM ET
Size
12.8 KB
Accession
0001209191-23-016099
Insider Transaction Report
Form 4
Newman Mark
SVP and CFO
Transactions
- Tax Payment
Common Stock
2023-03-01$34.84/sh−5,248$182,840→ 216,118.898 total - Award
Common Stock
2023-03-01+43,053→ 259,171.898 total - Award
Stock Option (Right to Buy)
2023-03-01+97,656→ 97,656 totalExercise: $34.84Exp: 2033-03-01→ Common Stock (97,656 underlying) - Award
Performance Stock Option (Right to Buy)
2023-03-01+96,277→ 96,277 totalExercise: $38.32Exp: 2033-03-01→ Common Stock (96,277 underlying)
Holdings
- 2,480(indirect: By Children)
Common Stock
- 32,155(indirect: By GRAT)
Common Stock
Footnotes (5)
- [F1]Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.
- [F2]Includes directly owned shares, restricted stock units and dividend equivalent units.
- [F3]Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
- [F4]These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
- [F5]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001524597
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:09 PM ET
- Size
- 12.8 KB